Friday’s FDA Vaccines and Related Biological Products (VRBPAC) meeting on Pfizer’s Covid-19 vaccine booster was so problematic as to make a reasonable person wonder whether our vaccine strategy was ever about science. UK approved and rolled out the Pfizer/BioNTech vaccine while FDA approves the COVID-19 vaccine for emergency use in the US, reportedly by American media. For those with a sense of logic, that’s before FDA approval of the Pfizer booster shot and before the Moderna and Johnson & Johnson even submit a request for approval! Friday’s VRBPAC meeting could have helped save face for the administration and restore confidence in the system, but it didn’t, or maybe, it couldn’t. This was followed unsurprisingly by multiple studies revealing that Covid-19 vaccine protection wanes over time.

Source: Forbes September 18, 2021 13:52 UTC